Meihua International Medical(US:MHUA) Prnewswire·2025-04-25 10:05Financial Performance - Revenues for the fiscal year 2024 were approximately $96.91 million, a slight decrease of 0.2% from $97.10 million in 2023 [3][9][10] - Gross profit increased by 0.3% to approximately $33.30 million, maintaining a gross margin of 34% for both years [3][12] - Income from operations decreased by 2.5% to approximately $14.31 million, while net income attributable to shareholders fell by 6.5% to approximately $10.84 million [3][19][21] Strategic Initiatives - The company focused on transitioning towards high-end medical products and enhancing operational efficiency, resulting in a stable revenue performance despite macroeconomic challenges [5] - A significant transformation included the sale of a controlling equity stake in Hainan Guoxie, reallocating capital towards higher-growth opportunities [6][22] - The construction of an integrated medical industrial park in Boao Hope City is underway, expected to be completed by mid-2025, aimed at consolidating R&D, manufacturing, and commercialization [6] Innovation and Technology - The launch of the AI-powered Speed Fox warehouse management platform in May 2024 improved supply chain efficiency [7] - Participation in a remote robotic lobectomy in July 2024 showcased the company's commitment to surgical innovation [7] - The company plans to expand its high-end medical product portfolio and integrate AI to enhance operational excellence [7]